These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 6323421)

  • 61. Application of semi-industrial monolithic columns for downstream processing of clotting factor IX.
    Branović K; Buchacher A; Barut M; Strancar A; Josic D
    J Chromatogr B Analyt Technol Biomed Life Sci; 2003 Jun; 790(1-2):175-82. PubMed ID: 12767330
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Human very low density lipoproteins: loss of electrophoretic mobility on enzymatic removal of sialic acid residues.
    Bijl VD; Reman FC
    Clin Chim Acta; 1975 Apr; 60(2):191-5. PubMed ID: 165020
    [TBL] [Abstract][Full Text] [Related]  

  • 63. An anti-EGF monoclonal antibody that detects intramolecular communication in factor IX.
    Persson KE; Knobe KE; Stenflo J
    Biochem Biophys Res Commun; 2001 Sep; 286(5):1039-44. PubMed ID: 11527405
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Cleavage and inactivation of Factor IX by granulocyte elastase.
    Takaki A; Enfield DL; Thompson AR
    J Clin Invest; 1983 Nov; 72(5):1706-15. PubMed ID: 6605369
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Effect of carbohydrate modifications of factor VIII/von Willebrand factor on binding to platelets.
    Goudemand J; Mazurier C; Samor B; Bouquelet S; Montreuil J; Goudemand M
    Thromb Haemost; 1985 Jun; 53(3):390-5. PubMed ID: 2864750
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Structural and functional characteristics of activated human factor IX after chemical modification of gamma-carboxyglutamic acid residues.
    Straight DL; Sherrill GB; Noyes CM; Trapp HG; Wright SF; Roberts HR; Hiskey RG; Griffith MJ
    J Biol Chem; 1985 Mar; 260(5):2890-3. PubMed ID: 3871774
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Replacing the first epidermal growth factor-like domain of factor IX with that of factor VII enhances activity in vitro and in canine hemophilia B.
    Chang JY; Monroe DM; Stafford DW; Brinkhous KM; Roberts HR
    J Clin Invest; 1997 Aug; 100(4):886-92. PubMed ID: 9259588
    [TBL] [Abstract][Full Text] [Related]  

  • 68. A novel blood coagulation factor IX/factor X-binding protein with anticoagulant activity from the venom of Trimeresurus flavoviridis (Habu snake): isolation and characterization.
    Atoda H; Morita T
    J Biochem; 1989 Nov; 106(5):808-13. PubMed ID: 2613688
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Configuration of substrate and products of N-acetylneuraminate pyruvate-lyase from Clostridium perfringens.
    Deijl CM; Vliegenthart JF
    Biochem Biophys Res Commun; 1983 Mar; 111(2):668-74. PubMed ID: 6301475
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Degradation of coagulation proteins by an enzyme from Malayan pit viper (Akistrodon rhodostoma) venom.
    Lollar P; Parker CG; Kajenski PJ; Litwiller RD; Fass DN
    Biochemistry; 1987 Dec; 26(24):7627-36. PubMed ID: 3322404
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Properties of a highly purified human plasma factor IX:c therapeutic concentrate prepared by conventional chromatography.
    Burnouf T; Michalski C; Goudemand M; Huart JJ
    Vox Sang; 1989; 57(4):225-32. PubMed ID: 2617959
    [TBL] [Abstract][Full Text] [Related]  

  • 72. SA11 rotavirus is specifically inhibited by an acetylated sialic acid.
    Willoughby RE; Yolken RH
    J Infect Dis; 1990 Jan; 161(1):116-9. PubMed ID: 2153181
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Activation of clotting factors in prothrombin complex concentrates as demonstrated by clotting assays for factors IXa and Xa.
    Elödi S; Váradi K
    Thromb Res; 1978 May; 12(5):797-807. PubMed ID: 675589
    [No Abstract]   [Full Text] [Related]  

  • 74. Replacement of isoleucine-397 by threonine in the clotting proteinase factor IXa (Los Angeles and Long Beach variants) affects macromolecular catalysis but not L-tosylarginine methyl ester hydrolysis. Lack of correlation between the ox brain prothrombin time and the mutation site in the variant proteins.
    Spitzer SG; Warn-Cramer BJ; Kasper CK; Bajaj SP
    Biochem J; 1990 Jan; 265(1):219-25. PubMed ID: 2105717
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Purification and properties of an abnormal blood coagulation factor IX (factor IXBm)/kinetics of its inhibition of factor X activation by factor VII and bovine tissue factor.
    Osterud B; Kasper CK; Lavine KK; Prodanos C; Rapaport SI
    Thromb Haemost; 1981 Feb; 45(1):55-9. PubMed ID: 7245126
    [TBL] [Abstract][Full Text] [Related]  

  • 76. A coagulation pathway on bovine aortic segments leading to generation of Factor Xa and thrombin.
    Stern DM; Nawroth PP; Kisiel W; Handley D; Drillings M; Bartos J
    J Clin Invest; 1984 Dec; 74(6):1910-21. PubMed ID: 6439737
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Propeptide processing during factor IX biosynthesis. Effect of point mutations adjacent to the propeptide cleavage site.
    Bristol JA; Furie BC; Furie B
    J Biol Chem; 1993 Apr; 268(10):7577-84. PubMed ID: 8463288
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Assembly of the intrinsic factor X activating complex--interactions between factor IXa, factor VIIIa and phospholipid.
    van Dieijen G; van Rijn JL; Govers-Riemslag JW; Hemker HC; Rosing J
    Thromb Haemost; 1985 Jun; 53(3):396-400. PubMed ID: 3931288
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Metal ion specificity of the conversion of bovine factors IX, IX alpha, and IXa alpha to bovine factor IXa beta.
    Byrne R; Amphlett GW; Castellino FJ
    J Biol Chem; 1980 Feb; 255(4):1430-5. PubMed ID: 7354038
    [No Abstract]   [Full Text] [Related]  

  • 80. Amphipathic helices support function of blood coagulation factor IXa.
    Blostein MD; Rigby AC; Furie BC; Furie B; Gilbert GE
    Biochemistry; 2000 Oct; 39(39):12000-6. PubMed ID: 11009614
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.